BofA Remains Positive on Colgate-Palmolive (CL) as Core Brands and Pet Nutrition Support Long-Term Outlook

Fisher Asset Management holds $1,889,726 worth of Colgate-Palmolive Company (NYSE:CL) shares, helping it secure a place on our list of billionaire Ken Fisher’s 10 consumer stock picks with the highest upside potential.

On October 8, 2025, BofA Securities reiterated its “Buy” rating on Colgate-Palmolive Company (NYSE:CL), reducing the price target from $98 to $88.

This update follows recent cautious revisions by a few other analysts. The firm’s price target revision for Colgate-Palmolive Company (NYSE:CL) is attributable to short-term pressure across the consumer staples sector amid softer household spending and elevated input costs. BofA Securities expects most of the stocks within the consumer staples sector to underperform in Q3, prompting a reduction in topline and EPS estimates across the sector.

At the same time, Colgate-Palmolive Company (NYSE:CL)’s diversified global footprint and strong portfolio, alongside its premium pet nutrition business, remain key drivers of its long-term growth.

Colgate-Palmolive Company (NYSE:CL) focuses on the manufacturing and sale of oral, personal, home care, and pet nutrition products globally.

While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Gold Royalty and Small-Cap Gold Stocks to Invest in Now and 11 Best Coal Stocks to Buy According to Hedge Funds.

Disclosure: None.